{"title": [{"text": "Speech-based Estimation of Bulbar Regression in Amyotrophic Lateral Sclerosis", "labels": [], "entities": [{"text": "Bulbar Regression", "start_pos": 27, "end_pos": 44, "type": "METRIC", "confidence": 0.9071792662143707}]}], "abstractContent": [{"text": "Amyotrophic Lateral Sclerosis (ALS) is a progressive neurological disease that leads to de-generation of motor neurons and, as a result, inhibits the ability of the brain to control muscle movements.", "labels": [], "entities": [{"text": "Amyotrophic Lateral Sclerosis (ALS)", "start_pos": 0, "end_pos": 35, "type": "TASK", "confidence": 0.8070012678702673}]}, {"text": "Monitoring the progression of ALS is of fundamental importance due to the wide variability in disease outlook that exists across patients.", "labels": [], "entities": [{"text": "Monitoring the progression of ALS", "start_pos": 0, "end_pos": 33, "type": "TASK", "confidence": 0.5778071939945221}]}, {"text": "This progression is typically tracked using the ALS functional rating scale-revised (ALSFRS-R), which is the current clinical assessment of a patient's level of functional impairment including speech and other motor tasks.", "labels": [], "entities": [{"text": "ALS functional rating scale-revised (ALSFRS-R)", "start_pos": 48, "end_pos": 94, "type": "METRIC", "confidence": 0.7367998574461255}]}, {"text": "In this paper, we investigated automatic estimation of the ALSFRS-R bulbar subscore from acoustic and articula-tory movement samples.", "labels": [], "entities": []}, {"text": "Experimental results demonstrated the AFSFRS-R bulbar subscore can be predicted from speech samples, which has clinical implication for automatic monitoring of the disease progression of ALS using speech information.", "labels": [], "entities": [{"text": "AFSFRS-R bulbar subscore", "start_pos": 38, "end_pos": 62, "type": "METRIC", "confidence": 0.8806137243906657}]}], "introductionContent": [{"text": "Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's disease) is a progressive neurological disease that destroys nerve cells and inhibits the normal voluntary motor function of the affected individual.", "labels": [], "entities": [{"text": "Amyotrophic Lateral Sclerosis (ALS", "start_pos": 0, "end_pos": 34, "type": "TASK", "confidence": 0.7177988469600678}]}, {"text": "The progression of this disease rapidly limits the patient's ability to perform normal daily tasks such as walking, speaking, and eventually even breathing.", "labels": [], "entities": []}, {"text": "Although there is currently no cure for ALS, early detection and accurate tracking of disease progression is crucial to the planning of treatment strategies and therapeutic intervention).", "labels": [], "entities": []}, {"text": "The currently used clinical measure for the disease progression is the patient self-reported ALSFRS-R score, which estimates the degree of functional impairment across motor tasks such as speaking and walking, as well as common daily tasks such as getting dressed and climbing the stairs).", "labels": [], "entities": [{"text": "ALSFRS-R score", "start_pos": 93, "end_pos": 107, "type": "METRIC", "confidence": 0.8951111137866974}]}, {"text": "ALSFRS-R has a collection of 12 questions, with a total score ranging from 0 to 48, which is composed of three factors: bulbar functions, fine and gross motor functions, and respiratory function (.", "labels": [], "entities": [{"text": "ALSFRS-R", "start_pos": 0, "end_pos": 8, "type": "DATASET", "confidence": 0.8398892283439636}]}, {"text": "Bulbar functions include speaking, salivating, and swallowing.", "labels": [], "entities": [{"text": "Bulbar", "start_pos": 0, "end_pos": 6, "type": "METRIC", "confidence": 0.9772388935089111}]}, {"text": "The efficacy of the ALSFRS-R for measuring motor-function and levels of self-sufficiency of individuals with ALS has been thoroughly demonstrated.", "labels": [], "entities": []}, {"text": "The ALSFRS-R has shown high inter-rater reliability, test-retest reliability, and internal consistency;).", "labels": [], "entities": [{"text": "reliability", "start_pos": 40, "end_pos": 51, "type": "METRIC", "confidence": 0.5989895462989807}, {"text": "reliability", "start_pos": 65, "end_pos": 76, "type": "METRIC", "confidence": 0.6305124163627625}, {"text": "consistency", "start_pos": 91, "end_pos": 102, "type": "METRIC", "confidence": 0.8119809627532959}]}, {"text": "Additionally, the ALSFRS-R is highly correlated with the clinical stage of ALS () and has been shown to be a useful predictor of patient survival).", "labels": [], "entities": [{"text": "ALSFRS-R", "start_pos": 18, "end_pos": 26, "type": "METRIC", "confidence": 0.7861760258674622}]}, {"text": "Despite the utility and reliability of the ALSFRS-R, it is only able to quantify specific degradations in motor function along a five point scale.", "labels": [], "entities": []}, {"text": "As such, it lacks the resolution to capture more subtle changes in motor function that can be observed through instrumentationbased measures.", "labels": [], "entities": []}, {"text": "Recently, there has been a surge of research using speech analytics to detect and track a range of neurological diseases such as Parkinson's (Orozco-Arroyave et al., 2016a,b;) and ALS.", "labels": [], "entities": []}, {"text": "Efforts towards tracking disease progression in this area have typically focused on the estimation of speech specific measures such as speech intelligibility (, speaking rate (, or severity (.", "labels": [], "entities": [{"text": "severity", "start_pos": 181, "end_pos": 189, "type": "METRIC", "confidence": 0.9947287440299988}]}, {"text": "While these efforts have shown success in the ability to objectively measure functional changes directly related to speech, whether speech can be used to measure functional impairment along other tasks in ALS remains largely unexplored.", "labels": [], "entities": []}, {"text": "In this paper we sought to address this question by examining how well speech and articulation data can predict the ALSFRS-R bulbar subscore (ranges from 0 to 12).", "labels": [], "entities": []}, {"text": "The long-term goal of this research is to develop objective measures for broad level motor function.", "labels": [], "entities": []}, {"text": "At this early stage, we focused on the bulbar score first.", "labels": [], "entities": []}, {"text": "To our knowledge, this paper is the first to predict ALSFRS-R (bulbar) score directly from speech information.", "labels": [], "entities": [{"text": "ALSFRS-R (bulbar) score", "start_pos": 53, "end_pos": 76, "type": "METRIC", "confidence": 0.6291108548641204}]}, {"text": "Two regression models, a simple linear ridge regression model and a machine learning algorithm (support vector machine), were used in the regression analysis.", "labels": [], "entities": [{"text": "regression analysis", "start_pos": 138, "end_pos": 157, "type": "TASK", "confidence": 0.9704826772212982}]}], "datasetContent": [], "tableCaptions": [{"text": " Table 1: Correlations between the speech measures and ALSFRS-R overall, bulbar, and non-bulbar scores.", "labels": [], "entities": [{"text": "ALSFRS-R overall", "start_pos": 55, "end_pos": 71, "type": "METRIC", "confidence": 0.8990780413150787}]}]}